FIFTH THIRD BANCORP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$644,000
-19.4%
6,4610.0%0.00%
-25.0%
Q4 2020$799,000
+27.0%
6,4610.0%0.00%
+33.3%
Q3 2020$629,000
-37.6%
6,4610.0%0.00%
-50.0%
Q2 2020$1,008,000
+8.0%
6,4610.0%0.01%
-14.3%
Q1 2020$933,000
-29.4%
6,4610.0%0.01%0.0%
Q4 2019$1,321,000
+154.5%
6,4610.0%0.01%
+133.3%
Q3 2019$519,000
-14.9%
6,4610.0%0.00%
-25.0%
Q2 2019$610,000
+10.5%
6,4610.0%0.00%0.0%
Q1 2019$552,000
+52.5%
6,4610.0%0.00%
+33.3%
Q4 2018$362,000
-31.4%
6,4610.0%0.00%0.0%
Q3 2018$528,000
+133.6%
6,4610.0%0.00%
+50.0%
Q2 2018$226,000
-11.7%
6,461
-48.2%
0.00%0.0%
Q1 2018$256,000
-27.5%
12,4610.0%0.00%0.0%
Q4 2017$353,000
-9.0%
12,4610.0%0.00%
-33.3%
Q3 2017$388,000
-1.5%
12,4610.0%0.00%0.0%
Q2 2017$394,000
-0.3%
12,461
-28.6%
0.00%0.0%
Q1 2017$395,00017,4610.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders